|
|
||||||||
1 INSERM U888 and Université Montpellier 1, France.
2 Département de Biologie Intégrée, CHU de Grenoble, France.
3 INSERM U708 and Université Paris 6, France.
Address correspondence to N. Tasnime Akabaraly, PhD, INSERM U888, Hôpital La Colombière, 39 Avenue Charles Flahault, BP 34493, 34093 Montpellier, Cedex 5, France. E-mail: akbaraly{at}montp.inserm.fr
Background. The hypothesis of carotenoids having a preventive role in cognitive impairment is suggested by their antioxidant properties.
Methods. We examined, in a cross-sectional analysis, the relationship between cognitive performance (assessed by the Mini-Mental State Examination, Trail Making Test Part B, Digit Symbol Substitution, Finger Tapping Test, and Word Fluency Test) and different plasma carotenoids (lutein, zeaxanthin, ß-cryptoxanthin, lycopene,
-carotene, and trans-ß-carotene and cis-ß-carotene) in a healthy elderly population (the EVA,"Etude du Vieillissement Artériel," study; n = 589, age = 73.5 ± 3 years).
Results. Logistic regression showed that participants with the lowest cognitive functioning (<25th percentile) had a higher probability of having low levels of specific plasma carotenoids (<1st quartile): lycopene and zeaxanthin. For zeaxanthin, odds ratios (ORs) were as follows: ORDSS = 1.97 (95% confidence interval [CI] = 1.213.20), ORFTT = 1.70 (CI = 1.052.74), and ORWFT = 1.82 (CI = 1.083.07); for lycopene, ORDSS = 1.93 (CI = 1.203.12) and ORTMTB = 1.64 (CI = 1.042.59).
Conclusion. Even if it is not possible to affirm if these low levels of carotenoids precede or are the consequence of cognitive impairment, our results suggest that low carotenoid levels could play a role in cognitive impairment. The biological significance of our findings needs further research.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|
| All GSA journals | The Gerontologist |
| Journals of Gerontology Series B: Psychological Sciences and Social Sciences | |